grey retatrutide People Are Already Taking This Unapproved New Weight-Loss Drug Don’t risk your health with

Retatrutide is an investigational injectable medication currently under clinical development by Eli Lilly

Rare but Serious Side Effects : Pancreatitis, gallbladder problems, and kidney issues

Glucagon has been shown to activate brown adipose tissue in animal models, increasing thermogenesis and energy expenditure

Your doctor may prescribe this under the names Adipex-P or Lomaira

Eating smaller portions might mean youre not getting enough essential vitamins and minerals

However, in a large study involving people with diabetes who had no comorbidities, GLP-1 RAs were not shown to increase the risk of developing pancreatitis at any time point up through 5 years of use.[ref][ref][ref][ref] The Cleveland Clinic now counsels that GLP-1 RA patients should be screened for pancreatitis risk factors, and a lower dose should be used to reduce the risk of pancreatitis.[ref] Related article : Pancreatitis and Genetic Risk Factors Gastroparesis: Case reports tie semaglutide to a risk of gastroparesis (very slow stomach emptying)